Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -14.72%614.56M | 46.55%877.02M | 24.61%789.43M | 21.18%3.14B | 40.23%1.18B | 25.30%720.6M | 24.16%598.46M | -7.78%633.55M | 38.53%2.59B | 61.10%843.72M |
| Operating revenue | -14.72%614.56M | 46.55%877.02M | 24.61%789.43M | 21.18%3.14B | 40.23%1.18B | 25.30%720.6M | 24.16%598.46M | -7.78%633.55M | 38.53%2.59B | 61.10%843.72M |
| Cost of revenue | -19.18%444.31M | 46.51%619.93M | 16.24%519.3M | 16.14%2.35B | 31.31%933.57M | 29.88%549.75M | 13.74%423.14M | -14.06%446.73M | 23.94%2.03B | 55.12%710.99M |
| Gross profit | -0.35%170.25M | 46.64%257.09M | 44.60%270.14M | 39.33%782.58M | 88.06%249.6M | 12.55%170.84M | 59.42%175.32M | 11.75%186.82M | 140.76%561.67M | 102.98%132.72M |
| Operating expense | 9.98%87.74M | 24.35%91.13M | 37.52%82.11M | -1.88%271.43M | -64.70%40.08M | 393.61%79.78M | -1.54%73.28M | -17.62%59.71M | 27.05%276.62M | -7.51%113.56M |
| Selling and administrative expenses | 32.57%67.5M | 46.77%96.44M | -1.65%58.82M | 3.10%253.15M | 30.10%76.72M | -22.28%50.92M | 15.17%65.71M | -6.57%59.81M | 42.73%245.54M | 101.53%58.97M |
| -General and administrative expense | 32.57%67.5M | 46.77%96.44M | -1.65%58.82M | 3.10%253.15M | 30.10%76.72M | -22.28%50.92M | 15.17%65.71M | -6.57%59.81M | 42.73%245.54M | 101.53%58.97M |
| Research and development costs | 15.18%10.28M | -108.99%-708K | 50.02%13.98M | 73.70%36.54M | 170.70%10.41M | 13.72%8.93M | 54.28%7.88M | 120.23%9.32M | 72.78%21.04M | 33.62%3.85M |
| Other operating expenses | -50.05%9.96M | -1,408.85%-4.6M | 198.80%9.31M | -281.88%-18.26M | -192.73%-47.05M | 134.85%19.94M | -102.49%-305K | -322.59%-9.42M | -70.04%10.04M | -44.02%50.74M |
| Operating profit | -9.39%82.51M | 62.64%165.96M | 47.92%188.03M | 79.32%511.16M | 993.29%209.52M | -32.86%91.06M | 187.03%102.04M | 34.22%127.11M | 1,731.35%285.05M | 133.39%19.16M |
| Net non-operating interest income (expenses) | 48.58%-10.93M | 39.23%-21.57M | 17.01%-26.41M | -2,899.36%-125.94M | -103.31%-55.96M | -292.70%-21.25M | -524.90%-35.5M | -907.05%-31.82M | 91.29%-4.2M | -1,482.63%-27.52M |
| Non-operating interest income | 72.15%6.81M | -31.44%5.41M | -41.66%3.69M | -80.99%21.23M | -83.91%3.07M | -88.37%3.95M | -74.64%7.89M | -77.04%6.32M | 197.79%111.67M | -11.88%19.05M |
| Non-operating interest expense | -36.57%12.99M | -42.11%22.39M | -23.15%25.47M | 39.24%128.16M | 58.64%54.45M | 6.30%20.47M | 106.28%38.68M | 68.11%33.15M | 33.33%92.05M | 81.00%34.32M |
| Total other finance cost | 0.40%4.75M | -2.53%4.59M | -7.50%4.63M | -20.22%19.01M | -62.67%4.57M | 27.78%4.73M | 17.85%4.71M | 28.83%5M | 42.74%23.82M | 178.93%12.25M |
| Other net income (expenses) | -129.39%-55.88M | 2,078.55%247.58M | 46.12%-38.46M | -162.29%-128.5M | -117.60%-20.24M | -158.03%-24.36M | -82.56%-12.51M | -226.99%-71.39M | 75.64%206.3M | 193.30%114.96M |
| Gain on sale of security | -684.74%-40.12M | 535.19%58.79M | 60.28%-9.8M | -319.86%-117.59M | -239.03%-86.27M | 3.92%6.86M | 9.03%-13.51M | -7,707.28%-24.67M | 4,420.96%53.48M | 152.25%62.05M |
| Special income (charges) | 131.68%204K | 69.05%-13K | -499.19%-2.22M | 52.38%-1.04M | 100.77%14K | -600.00%-644K | 84.78%-42K | ---370K | -109.82%-2.19M | -55.03%-1.82M |
| -Gain on sale of property,plant,equipment | 131.68%204K | 69.05%-13K | -499.19%-2.22M | 52.38%-1.04M | 100.77%14K | -600.00%-644K | 84.78%-42K | ---370K | -325.68%-2.19M | -55.03%-1.82M |
| Other non-operating income (expenses) | 400.00%330K | 38,100.00%382K | 10,200.00%404K | 78.57%975K | 91,000.00%911K | --66K | -99.82%1K | ---4K | --546K | --1K |
| Income before tax | -65.44%15.71M | 625.44%391.97M | 415.32%123.16M | -47.30%256.72M | 25.07%133.33M | -75.90%45.46M | 45.83%54.03M | -84.57%23.9M | 474.51%487.15M | 634.82%106.61M |
| Income tax | -58.28%15.87M | 294.39%71.09M | 72.50%53.41M | -32.82%84.87M | -108.08%-2.14M | -6.24%38.03M | -22.84%18.02M | -13.77%30.96M | 2,926.96%126.34M | 687.85%26.51M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -102.13%-158K | 791.15%320.89M | 1,087.85%69.75M | -52.37%171.84M | 69.14%135.47M | -94.98%7.43M | 162.97%36.01M | -105.94%-7.06M | 304.21%360.82M | 619.31%80.09M |
| Net income continuous operations | -102.13%-158K | 791.15%320.89M | 1,087.85%69.75M | -52.37%171.84M | 69.14%135.47M | -94.98%7.43M | 162.97%36.01M | -105.94%-7.06M | 304.21%360.82M | 619.31%80.09M |
| Noncontrolling interests | -1,600.00%-17K | -50.00%-3K | -140.00%-12K | 64.52%-11K | 69.23%-4K | 92.31%-1K | -2K | 0.00%-5K | 73.73%-31K | -116.67%-13K |
| Net income attributable to the company | -101.90%-141K | 791.11%320.89M | 1,088.72%69.76M | -52.38%171.85M | 69.12%135.47M | -94.98%7.43M | 162.98%36.01M | -105.93%-7.06M | 303.71%360.85M | 619.60%80.11M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -101.90%-141K | 791.11%320.89M | 1,088.72%69.76M | -52.38%171.85M | 69.12%135.47M | -94.98%7.43M | 162.98%36.01M | -105.93%-7.06M | 303.71%360.85M | 619.60%80.11M |
| Diluted earnings per share | -101.62%-0.0003 | 825.00%0.74 | 900.00%0.16 | -51.81%0.4 | 77.78%0.32 | -94.12%0.02 | 166.67%0.08 | -107.41%-0.02 | 277.27%0.83 | 550.00%0.18 |
| Basic earnings per share | -101.62%-0.0003 | 825.00%0.74 | 900.00%0.16 | -53.01%0.39 | 72.22%0.31 | -94.12%0.02 | 166.67%0.08 | -107.41%-0.02 | 277.27%0.83 | 550.00%0.18 |
| Dividend per share | 0 | 0 | 0 | 33.33%0.16 | 33.33%0.16 | 0 | 0 | 0 | 0.00%0.12 | 0.00%0.12 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.